Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)
A Dual Energy X-Ray Absorptiometry Comparison Of Periprosthetic Bone Loss Between Patients Undergoing Hip Resurfacing Surgery And Total Hip Arthroplasty
1 other identifier
observational
31
1 country
1
Brief Summary
This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 22, 2011
CompletedFirst Posted
Study publicly available on registry
May 24, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedApril 26, 2019
April 1, 2019
9.9 years
May 22, 2011
April 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone Mineral Density
To evaluate the bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to the bone loss in the proximal femur resulting from total hip arthroplasty.
Baseline, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
Secondary Outcomes (1)
Harris Hip Score
Pre-operative, 6 weeks, 6 months, 1, 2, 3, 4, and 5 years post-operative
Study Arms (2)
Hip Resurfacing
Total Hip Arthroplasty
Interventions
Eligibility Criteria
Adult patients undergoing hip replacement or resurfacing for osteoarthritis
You may qualify if:
- Age of at least 20 years
- Osteoarthritis
- Elective Total Hip Arthroplasty / Resurfacing
- Signed Informed Consent
You may not qualify if:
- Osteoporosis
- Revisions
- Femoral dysplasia
- Trochanteric osteotomy
- Inflammatory arthritis
- Breast-feeding, pregnancy, or women of child-bearing potential without documentation of a negative pregnancy test and not utilizing contraception
- Patients with a history of having taken or currently taking PTH, fluoride therapy or strontium ranelate or patients taking other chronic medications that in the Investigator's opinion are known to affect bone mineral density in a substantial way
- Patients with severe medical condition(s) that in the view of the Investigator prohibits participation in the study
- Use of any other investigational agent in the last 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Spokane Joint Replacement Center
Spokane, Washington, 99218, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Scott, MD
Spokane Joint Replacement Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
May 22, 2011
First Posted
May 24, 2011
Study Start
December 1, 2008
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
April 26, 2019
Record last verified: 2019-04